A life-time perspective on the effects of an early invasive compared with a non-invasive treatment strategy in patients with non-ST-elevation acute coronary syndrome - the FRISC II 15 years follow-up
5-year outcomes after implantation of biodegradable polymer-coated biolimus-eluting stents versus durable polymer-coated sirolimus-eluting stents in unselected patients
10-year follow-up of clinical outcomes in a randomized trial comparing routine invasive versus selective invasive management in patients with non ST-segment elevation acute coronary syndrome.
Comparative Efficacy of Coronary Artery Bypass Surgery Versus Percutaneous Coronary Intervention in Diabetic Patients with Multivessel Coronary Artery Disease With or Without Renal Dysfunction
ABSORB Japan: 2-year clinical results from a randomized trial evaluating the Absorb Bioresorbable Vascular Scaffold vs. metallic drug-eluting stent in de novo native coronary artery lesions